Salvatore Caponnetto | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Genomic landscape and survival analysis of ctDNA “neo-RAS wild-type” patients with originally RAS mutant metastatic colorectal cancer	FRONTIERS IN ONCOLOGY	2023
Lenvatinib Versus Sorafenib in Advanced Hepatic Cell Carcinoma: A Double Center Retrospective Analysis	ANTICANCER RESEARCH	2023
The value of the multidisciplinary team in metastatic renal cell carcinoma: Paving the way for precision medicine in toxicities management	FRONTIERS IN ONCOLOGY	2023
Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study	CANCERS	2023
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review	CANCER BIOTHERAPY & RADIOPHARMACEUTICALS	2023
Selective Internal Radiation Therapy (SIRT): a new emerging role for Breast Cancer Liver Metastases	TUMORI	2023
RAS mutation conversion in bevacizumab-treated metastatic colorectal cancer patients: a liquid biopsy based study	CANCERS	2022
Prognostic value of the {BIO}-Ra Score in metastatic castration-resistant prostate cancer patients treated with Radium-223 after the European Medicines Agency Restricted use: secondary investigations of the multicentric {BIO}-Ra Study	CANCERS	2022
Response to immunotherapy in KRAS G12C mutated NSCLC: a single-centre retrospective observational study	ONCOTARGET	2022
Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis	ANTICANCER RESEARCH	2022
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONO	CLINICAL COLORECTAL CANCER	2022
True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature	CANCER LETTERS	2021
Impact of sarcopenia and inflammation on patients with advanced non-small cell lung cancer (Ncscl) treated with immune checkpoint inhibitors (icis): a prospective study	CANCERS	2021
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO	BRITISH JOURNAL OF CANCER	2021
About RAS Mutation Clearance in Plasma ctDNA From RAS-Mutant Colorectal Cancer Patients	JCO PRECISION ONCOLOGY	2021
A Comparison Between First-, Second- and Third-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small-Cell Lung Cancer and Brain Metastases	JOURNAL OF MOLECULAR PATHOLOGY	2021
Exploratory pilot study of circulating biomarkers in metastatic renal cell carcinoma	CANCERS	2020
Efficacy and tolerability of selective internal radiotherapy with Yttrium-90 as consolidation treatment after chemotherapy in metastatic colorectal cancer	CLINICAL COLORECTAL CANCER	2020
Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer	ONCOTARGET	2020
Circulating methylated DNA to monitor the dynamics of RAS mutation clearance in plasma from metastatic colorectal cancer patients	CANCERS	2020